Overall rank by patents
#39,328
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, active 2022–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
CD holds 6 US patents across 4 technology areas, rank #39,328 of 50,000 tracked assignees.
CD Acquisitions, Llc has been granted 6 US utility patents between 2022 and 2023, placing CD Acquisitions, Llc at rank #39,328 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, CD Acquisitions, Llc is one of the more focused assignees in the PatentsView dataset. By volume, CD sits between CBG Partners, Llc (6 patents, rank #39,324) and Cellcentric Ltd (6 patents, rank #39,332) - the closest US assignees by grant volume. The composite Innovation Score of 43.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2023, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. CD Acquisitions, Llc's 15.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CD Acquisitions, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CBG Partners, LLC
6 patents
CCCC Highway Consultants Co. Ltd.
6 patents
CCD Holdinas LLC
6 patents
CCP TECHNOLOGY GMBH
6 patents
CDT OXFORD LIMITED
6 patents
CEFO CO., LTD.
6 patents
CELL ID PTE LTD
6 patents
CELLCENTRIC LTD
6 patents
CD Acquisitions, LLC
6 patents
What this shows CD holds 6 patents at rank #39,328, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #39,328 in granted patent volume.
Other assignees with the most granted patents in CD's primary technology class.
CD's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 16.7% |
| 2023 | 5 | 83.3% |
Top 4 of 4 technology areas
Overall rank by patents
#39,328
Across all tracked assignees
43.2 out of 100
How to use this portfolio
CD's 6 grants land it in the top 29% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.